(1) Background: Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the most common malignancies globally. An early diagnosis of this disease is crucial, and the detection of gene mutations in circulating tumour DNA (ctDNA) through a liquid biopsy is a promising non-invasive diagnostic method. This review aims to provide an overview of ctDNA mutations in HNSCC patients and discuss the potential use of this tool in diagnosis and prognosis. (2) Methods: A systematic search for articles published in the English language between January 2000 and April 2021 in the Medline and Scopus databases was conducted. (3) Results: A total of 10 studies published in nine publications were selected and analysed. Altogether, 390 samples were obtained from HNSCC patients, and 79 control samples were evaluated. The most often explored gene mutation in ctDNA was TP53. (4) Conclusions: The examination of a larger group of gene mutations and the use of a combination of multiple detection methods contribute to a higher detection rate of mutated ctDNA. More studies are necessary to verify these conclusions and to translate them into clinical practice.
Head and neck squamous cell carcinoma is one of the most aggressive tumours and is typically diagnosed too late. Late diagnosis requires an urgent decision on an effective therapy. An individualized test of chemosensitivity should quickly indicate the suitability of chemotherapy and radiotherapy. No ex vivo chemosensitivity assessment developed thus far has become a part of general clinical practice. Therefore, we attempted to explore the new technique of coherence-controlled holographic microscopy to investigate the motility and growth of live cells from a head and neck squamous cell carcinoma biopsy. We expected to reveal behavioural patterns characteristic for malignant cells that can be used to imrove future predictive evaluation of chemotherapy. We managed to cultivate primary SACR2 carcinoma cells from head and neck squamous cell carcinoma biopsy verified through histopathology. The cells grew as a cohesive sheet of suspected carcinoma origin, and western blots showed positivity for the tumour marker p63 confirming cancerous origin. Unlike the roundish colonies of the established FaDu carcinoma cell line, the SACR2 cells formed irregularly shaped colonies, eliciting the impression of the collective invasion of carcinoma cells. Time-lapse recordings of the cohesive sheet activity revealed the rapid migration and high plasticity of these epithelial-like cells. Individual cells frequently abandoned the swiftly migrating crowd by moving aside and crawling faster. The increasing mass of fast migrating epithelial-like cells before and after mitosis confirmed the continuation of the cell cycle. In immunofluorescence, analogously shaped cells expressed the p63 tumour marker, considered proof of their origin from a carcinoma. These behavioural traits indicate the feasible identification of carcinoma cells in culture according to the proposed concept of the carcinoma cell dynamic phenotype. If further developed, this approach could later serve in a new functional online analysis of reactions of carcinoma cells to therapy. Such efforts conform to current trends in precision medicine.
19 October 2025 in European Archives of Oto-Rhino-Laryngology
Aim: The study compares the efficacy of adenoidectomy and myringotomy on the treatment of otitis media with effusion (OME) in children depending on the size of adenoids (AV) and age. Material and methods: A total of 509 children with OME lasting at least 3 months, who underwent endoscopic adenoidectomy (AT) and myringotomy without the insertion of a ventilation tube in the years 2010–2019 were enrolled in the study. The efficacy of AT and myringotomy on OME was evaluated with regard to the size of the adenoids, their relationship to the tubal tori, the viscosity of middle ear effusion and the age of the child. To evaluate the effect of age, children were divided into two groups—up to 4 years and over 4 years. Results: The efficacy of AT and myringotomy in OME treatment was demonstrated in both groups. Within the entire group, a significantly greater benefit of AT and myringotomy was found in children with adenoids in contact with the tubal tori (grade B) or compressing them (grade C) (p = 0.039). Other parameters were not statistically significant. Neither the size of the adenoids relative to the choanae, nor the children age, nor the type of middle ear effusion (serous, mucous) had an effect on the treatment. Conclusion: AT and myringotomy is an effective surgical procedure in the treatment of OME not only in children older than 4 years, but also in younger children. The effect of the surgery is affected by the contact of adenoids to tubal tori.
9 November 2026 in Acta Oto-Laryngologica Case Reports
Emphysema (stemming from Greek ἐμφύσημα – emphysēma – inflation) is a pathological accumulation of air (or other gases) in the body tissue. Such accumulation could happen in the subcutaneous tissue...